<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174913</url>
  </required_header>
  <id_info>
    <org_study_id>099/2557</org_study_id>
    <nct_id>NCT02174913</nct_id>
  </id_info>
  <brief_title>Awakening in Spine Surgery: A Comparison Between Clinical Signs and Bispectral Index</brief_title>
  <official_title>Awakening in Spine Surgery Patients Having Neurophysiologic Monitoring: A Comparison Study Between Clinical Signs and Bispectral Index (BIS) Guided Target Controlled Infusion(TCI) of Propofol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      BIS is one of several equipments used to monitor depth of anesthesia.Some studies found BIS
      can reduce total propofol dose when being used with TCI.The objective is to compare awakening
      time after spine surgery between using clinical signs and bispectral index (BIS) guided
      target controlled infusion(TCI) of propofol in patients having neurophysiologic monitoring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      34 patients undergoing spine surgery will be enrolled and randomly devided into two groups.
      We exclude patients who age under 18 and over 80 years, preoperative hemodynamics
      instability, propofol allergy, receiving drugs interfered with EEG, liver disease, BMI over
      30 kg/m2. Before induction the patient will be given 0.9% NaCl or acetate Ringer solution 7
      ml/kg. Standard monitorings are used to all patients.

      Control group will receive fentanyl 1 mcg/kg and then fentanyl infusion 1 mcg/kg/hr and
      propofol TCI target 3-7 mcg/ml until asleep and then atracurium 0.5 mg/kg was given to
      facilitate endotracheal intubation. The patients will be ventilated with air:oxygen 1:1 L.
      The TCI propofol will be adjusted by clinical monitoring. If the patient has minor movement,
      the propofol TCI will be increased incrementally to 0.5 mcg/ml higher level but if major
      movement occurs the dose will be increased to1.0 mcg/ml higher. When hypotension occurs, this
      will be treated by fluid loading 200 ml in 10 min if it is not improved, then ephedrine or
      norepinephrine will be given and the TCI dose will be decreased by 0.5 mcg/ml lower level but
      not lower than 3.0 mcg/ml. Hypertension will be treated by fentanyl bolus 0.5 mcg/kg and
      increasing TCI dose to 0.5 mcg/ml higher level but not more than 7 mcg/ml. If hypertension
      persist, the nicardipine or diltiazem will be given.

      Intervention group receives fentanyl 1 mcg/kg and then fentanyl infusion 1 mcg/kg/hr and
      propofol by TCI 3-7 mcg/ml until asleep and then atracurium 0.5 mg/kg was given to facilitate
      endotracheal intubation. The patients will be ventilated with air:oxygen 1:1 L. Propofol will
      be adjusted by BIS monitoring. If the movement occurs and BIS 40-60, fentanyl 0.5 mcg/kg will
      be given, BIS &gt; 60, TCI dose will be increased 0.5 mcg/ml higher level until BIS 40-60. When
      hypotension occurs, if BIS 40-60, will be treated by load fluid 200 ml in 10 mins, then
      ephedrine or norepinephrine will be given, If BIS &lt; 40 the TCI dose will decrease 0.5 mcg/ml
      but not lower than 3.0 mcg/ml. Hypertension occurs, if BIS &gt; 60 will be treated by fentanyl
      bolus 0.5 mcg/kg and TCI dose will be increased 0.5 mcg/ml higher level but not more than 7
      mcg/ml if not improved, nicardipine or diltiazem will be given. if BIS 40-60, nicardipine or
      diltiazem will be given.

      This record data include awakening time, total propofol dose,intraoperative complications,
      hemodynamics parameters.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Awakening time</measure>
    <time_frame>4 hr</time_frame>
    <description>Awakening time from finish operation to patient adequate tidal volume, open eye,follow command and extubation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total propofol dosage</measure>
    <time_frame>12 hr</time_frame>
    <description>total propofol dosage &gt; propofol dose from start to end of the operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Spine Diseases</condition>
  <arm_group>
    <arm_group_label>bispectral index</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bispectral index guides the target controlled infusion of propofol by keeping BIS 40-60 throughout operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clinical signs</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Clinical signs (heart rate, blood pressure and movement) guide target controlled infusion(TCI) of propofol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bispectral index</intervention_name>
    <description>Bispectral index (BIS) is one of several technologies used to monitor depth of anesthesia.</description>
    <arm_group_label>bispectral index</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spine surgery with neurophysiology monitoring

          -  ASA 1-3

          -  elective case

          -  cooperate patients

          -  Not receive drugs interfere with EEG

        Exclusion Criteria:

          -  unstable hemodynamics

          -  liver disease

          -  propofol allergy

          -  BMI &gt; 30

          -  complete cord lesion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manee Raksakietisak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manee Raksakietisak, MD</last_name>
    <phone>6624197990</phone>
    <email>simrs@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Narin Plailaharn, MD</last_name>
    <phone>66850119326</phone>
    <email>plyradian@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mahidol University, siriraj hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manee Raksakietisak, MD</last_name>
      <phone>6624197990</phone>
      <email>simrs@mahidol.ac.th</email>
    </contact>
    <contact_backup>
      <last_name>Narin Plailaharn, MD</last_name>
      <phone>66850119326</phone>
      <email>plyradian@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>June 25, 2015</last_update_submitted>
  <last_update_submitted_qc>June 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Awakening time</keyword>
  <keyword>Bispectral index</keyword>
  <keyword>clinical signs</keyword>
  <keyword>neurophysiologic monitoring</keyword>
  <keyword>spine surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>September 19, 2016</submitted>
    <returned>November 7, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

